Weekly Policy Update: November 12, 2026

Next week, HLTH USA 2026 is taking place in Las Vegas from November 15-18, 2026, convening over 12,000 attendees from across employers, health technology, investing, government, life sciences, payers, and providers.
In addition to industry announcements, the Goldsand Friedberg team expects to hear policy updates from government officials who will be speaking during main stage sessions. This includes HHS Deputy Secretary nominee and CMS Director of Medicare Chris Klomp, who is opening the first full day of the conference in a mainstage session about “Fixing Healthcare’s Price Problem.” Other spotlights on the agenda include:
Monday, November 16:
Virtual live remarks from CMS Administrator Dr. Mehmet Oz
Move Fast and Fix Healthcare's Data Problem: Main stage session with U.S. DOGE Service Administrator, Amy Gleason, and Zus Health CEO, Jonathan Bush
Fund the Impossible: How ARPA-H Is Betting on Biotech Supremacy: Fireside chat with ARPA-H CMO Dr. Rafid Fadul
(CMS) Access Included: Panel discussion with CMS Innovation Center’s Chief AI & Technology Officer, Jacob Shiff, and ACCESS Model participants
Tuesday, November 17:
Reimagining Interoperability for the Agentic Era: Panel discussion with CMS Deputy Administrator Stephanie Carlton
The Government's Playbook for Clinical AI: Panel discussion including leaders from FDA and ARPA-H
If you are going to the conference, and would like to meet, please reach out to Ross Friedberg (ross@gflaw.tech) or Marc Goldsand (marc@gflaw.tech).
This Week's Highlights
FTC and Hims and Hers litigation expands: FTC added five states to its complaint in federal district court against Hims and Hers, first filed in July 2026, which alleges improper health data sharing with third-party advertising platforms and deceptive billing practices. The amended complaint alleges violations of each new co-plaintiff state’s consumer protection laws.
FDA is requesting public input: FDA issued a request for information asking for input on challenges with the requirement for patient-level real-world data for drug and biologic marketing applications (comments due January 11, 2027), and released a discussion paper on regulatory considerations for robotic medical devices with autonomous or remote operation capabilities (comments due January 5, 2027).
New York establishes independent safety testing: New York Gov. Kathy Hochul launched the New York Center for AI Responsibility and Research at Binghamton University, bringing together more than 80 researchers for independent AI safety testing. The state also opened a registration portal for large frontier AI developers under the Responsible AI Safety and Education (RAISE) Act, which requires them to register by Jan. 1, 2027.
Oura plans to acquire Counsel Health: Oura agreed to acquire Counsel Health, an AI-enabled virtual primary care company that combines chatbot guidance with access to physicians, for $625 million in cash. The transaction, expected to close by the end of 2026, would expand the companies' existing partnership pairing Oura's wearable biometric data with Counsel’s medical guidance and care.
What's Next
As the dust settles from the U.S. midterm elections, health tech stakeholders are speculating what the results and a Democratic-controlled Congress will mean for them. Oversight hearings and an overall focus on affordability will most likely dominate health care conversations in Congress, meaning we expect most digital health policy updates to be driven by HHS.
We will be watching closely for announcements from administration officials between now and the end of the year, particularly as HHS continues to push key digital health policy efforts, like CMS’ payment models for tech-enabled care, FDA’s attempt to oversee clinical AI, and ONC’s regulatory posture on information blocking.
Please let us know if you have any questions about how to interpret what these news reports and announcements mean for your business.
Comments